Gilead: Expansion Of Livdelzi For PBC Continues With European Marketing Approval
Gilead Sciences sees strong growth in HIV & oncology with BIKTARVY & TRODELVY. Learn about upcoming drugs & market potential ...
Promising Pharmaceutical Stocks To Keep An Eye On – March 19th
Eli Lilly and Company, Gilead Sciences, and D-Wave Quantum are the three Pharmaceutical stocks to watch today, according to ...
Stocktwits on MSN6d
Gilead Stock Wobbles On Federal HIV Funding Cut Buzz, But Retail And Analysts Stay Unfazed
Shares of Gilead Sciences, Inc. dropped nearly 2.5% on Wednesday and extended losses after hours following a report that the ...
Buy 3 U.S. Giants Flying High Year to Date Defying Severe Volatility
U.S. stock markets have been enduring severe volatility over the past month. Wall Street’s recent turmoil is broad-based. The ...
Gilead Stock Falls on Report Trump Administration Wants to Cut HIV-Prevention Funding
Gilead Sciences stock declined Wednesday after The Wall Street Journal reported the Department of Health and Human Services ...
Gilead Stock (NYSE:GILD) Slumps on HIV Funding Cuts Report
Gilead Sciences (GILD) stock fell after The Wall Street Journal reported that the Health and Human Services Department is looking at ...